Search

everythinglearnresearchcommunity

for

Search:↓

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Tinea incognito in Iran commonly affects adults and mimics other skin conditions.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Grape seed extract may safely and effectively help prevent lung cancer.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Unripe banana extract may promote hair growth similar to minoxidil.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Methotrexate side effects vary by race and sex.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Zidovudine may cause hair loss in advanced-stage HIV patients.

Prolonged linseed ingestion is safe for rabbits.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

A liquid protein diet caused hair loss in a young woman.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.